Abstract
Objective
To determine whether treatment with a protocolized sepsis guideline in the emergency department (ED) was associated with a lower burden of organ dysfunction (OD) by hospital day 2 compared to non-protocolized usual care in pediatric patients with severe sepsis.
Design
Retrospective cohort study
Setting
Tertiary care children’s hospital from January 1, 2012–March 31, 2014.
Measurements and Main Results
Subjects with international consensus defined severe sepsis and pediatric intensive care unit (PICU) admission within 24 hours of ED arrival were included. The exposure was the use of a protocolized ED sepsis guideline. The primary outcome was complete resolution of OD by hospital day 2. One hundred eighty nine subjects were identified during the study period. Of these, 121 (64%) were treated with the protocolized ED guideline and 68 were not. There were no significant differences between the groups in age, sex, race, number of comorbid conditions, ED triage level, or OD on arrival to the ED. Patients treated with protocolized ED care were more likely to be free of OD on hospital day 2 after controlling for sex, comorbid condition, indwelling central venous catheter, PIM-2 score, and timing of antibiotics and intravenous fluids (adjusted OR 4.2, 95% CI 1.7, 10.4).
Conclusions
Use of a protocolized ED sepsis guideline was independently associated with resolution of OD by hospital day 2 compared to non-protocolized usual care. These data indicate that morbidity outcomes in children can be improved with the use of protocolized care.
MeSH Keywords: Pediatrics, Sepsis, Critical Care, Emergency Medicine
Introduction
There are over 75,000 cases of pediatric sepsis annually in the United States, resulting in significant morbidity and mortality, and health care costs.1–3 Multiple studies have demonstrated that adherence to protocolized sepsis treatment guidelines can improve both process metrics and resource utilization in pediatric sepsis, including decreased time to antibiotics and fluid resuscitation4,5 and a shorter hospital length of stay.6
While several studies have reported an association of early antibiotics with improved mortality rates and decreased duration of organ dysfunction,7 data showing a direct impact of protocolized treatment guidelines on patient clinical outcomes are lacking in pediatric studies. The relatively low mortality rate due to pediatric sepsis, particularly in children with initial sepsis care in the ED setting (compared to hospital-acquired sepsis), has limited the power of quality improvement studies to demonstrate that protocolized care improves this important clinical outcome8,9. However, morbidity related to organ dysfunction remains substantial in pediatric sepsis, even in centers with protocol based early and aggressive sepsis care in place.10
Importantly, OD has been associated with increased risk of mortality and higher resource utilization and costs in pediatric sepsis.1,11–13 In particular, the number of affected organ systems and the persistence of organ dysfunction despite resuscitation reflects the severity of illness and has been associated with adverse outcomes, including mortality in sepsis.12,13 Reflecting this point, recent randomized trials in pediatric sepsis and other critical illnesses have used duration of organ failure as the primary efficacy outcome rather than mortality.14,15 Importantly, studies have indicated that over 90% of sepsis related organ dysfunction occurs in the first two days of hospitalization.8, 16, 17 We therefore sought to determine whether treatment with a protocolized sepsis guideline in the ED was associated with a lower burden of OD by hospital day 2 compared to non-protocolized usual care in pediatric patients with severe sepsis.
Methods
Study Design and Setting
This was a retrospective cohort study at a tertiary care children’s hospital with approximately 90,000 emergency department (ED) visits and 4000 pediatric intensive care unit (PICU) admissions annually. The Institutional Review Board at The Children’s Hospital of Philadelphia (CHOP) approved this research under a waiver of informed consent.
Study Population
We included subjects ages >56 days and <18 years of age treated in our ED from January 1, 2012 through March 31, 2014 and who had severe sepsis or septic shock within 24 hours of ED triage and required PICU admission. Severe sepsis and septic shock (referred to collectively as severe sepsis) was defined using international consensus guidelines.18 All patients treated in the PICU during the study period were screened for severe sepsis using a standardized form completed by a multidisciplinary PICU team as part of routine clinical care. All patients with a positive initial screen were reviewed by two critical care physicians to confirm the diagnosis of severe sepsis. Discrepancies in determination of eligibility were resolved by consensus at monthly meetings (SW, JF, FB). We excluded infants <56 days because at our institution, these infants are treated according to a separate febrile young infant protocol due to the unique physiology and pathogens seen in this young age group.
Data Collection
The data source for this study was the CHOP Sepsis Registry. The registry contains over 150 data elements extracted either directly from the electronic health record (EHR) using locally developed computer algorithms or by manual medical record review. Automated extracted data elements include demographic data, past medical history, ED vital signs, ED and hospital laboratory results, ED and hospital therapies, ED and hospital length of stay, and vital status at discharge.7,19 The structure and process of the automated data extraction has been previously described.20–22 Data elements available as text fields (e.g., x-ray results, physical exam findings) were extracted by medical record review. PICU severity of illness scores were obtained from the virtual PICU23 and included the Pediatric Index of Mortality (PIM-2)24 and the Pediatric Risk of Mortality III (PRISM-III25,) scores. PIM2 is determined based on data from the first hour of PICU care, and PRISM III is determined based on data from the first 24 hours of PICU care.24,25
Exposure
The exposure was utilization of a protocolized sepsis guideline, including a computerized physician order set in the ED. Details of the protocol are included in Appendix 1. The protocol was available for all patients during the study period but utilization was at the discretion of the treatment team. Treatment teams were educated to identify early signs of severe sepsis/septic shock and utilize the treatment protocol, and were sent monthly reminders to reinforce the use of the guideline. We defined protocol use as patients for whom the sepsis order set was utilized, identified by a default computer entry automatically applied to all patients for whom the order set was activated. We defined usual care as patients who were cared for without utilization of the sepsis order set. The protocol referred to within the text and Appendix is the one that was in place during the study period. The institutional protocol has since had several updates.
Outcomes
The primary outcome was complete resolution of OD by hospital day 2. OD was determined at ED presentation, PICU admission, and on two subsequent hospital days using international consensus criteria for sepsis-associated organ dysfunction.18 Utilizing these criteria, the presence or absence of cardiovascular, respiratory, neurologic, renal, hepatic, and hematologic dysfunction were determined on ED arrival, hospital admission, hospital day 1 and 2. Utilizing these criteria, the presence or absence of cardiovascular, respiratory, neurologic, renal, hepatic, and hematologic dysfunction were determined on ED arrival, hospital admission, hospital day 1 and 2. Consistent with consensus guidelines for organ dysfunction in pediatric sepsis, we excluded pre-existing chronic organ dysfunction (for example, a patient with known pre-existing chronic thrombocytopenia due to a non-sepsis condition with thrombocytopenia at the usual range) and only included new or worsening organ dysfunction.18 Secondary outcomes included PICU and hospital length of stay (LOS), time from ED triage to initial antibiotic and fluid therapy, need for transfer to a higher level of care within 24 hours of admission, and mortality. Covariates examined included age, sex, PRISM-III and PIM2 scores, ED triage emergency severity index level, and the presence of complex chronic conditions (CCC). The CCC classification scheme uses a validated grouping of ICD9-CM codes to categorize comorbid disease processes into the following nine categories: malignancy, hematology/immune, respiratory, gastrointestinal, metabolic, neuromuscular, cardiovascular, renal, and other congenital abnormalities.26, 27
Statistical Analysis
Descriptive data are presented as medians with interquartile ranges (IQR) for continuous variables and frequencies with percentages for categorical variables. The Wilcoxon rank sum and Fisher’s exact tests were used to compare continuous and categorical variables, respectively. We used multivariable logistic regression to determine the independent association of protocol use with OD resolution by day 2. Covariates were selected a priori based on biological plausibility, data availability, and prior studies,28–30 and were included in the final model if found to be significant at the p<0.2 level on univariate analysis. All statistical analyses were carried out using Stata 12.1 (College Station, Tx).
Results
One hundred eight-nine PICU patients with severe sepsis were identified during the study period. Of these, 121 (64%) were treated with the sepsis protocol/order set in the ED and 68 (36%) were treated with usual care in the ED. There were no significant differences between protocol and usual care patients in terms of age, sex, race, or number of CCC (Table 1). The monthly proportion of patients treated with the protocol during the study period is shown in Supplemental Figure 1. There were no significant differences in ED triage level or OD present on ED arrival in protocol vs. usual care patients. Protocol patients had higher initial median lactate levels in the ED (Table 1). On arrival to the PICU, there was no statistically significant differences in either median PIM-2 and PRISM-III scores, or OD between usual care patients and protocol patients (Table 2).
Table 1.
Sepsis Protocol in ED | |||
---|---|---|---|
| |||
Demographic | Yes | No | p |
Total n | 121 | 68 | |
N (%)
|
|||
Age | |||
57 days- <1 year | 15 (12.4) | 7 (10.3) | 0.95 |
1 year- <4 years | 27 (22.3) | 16 (23.5) | |
4 years-<13 years | 53 (43.8) | 32 (47.1) | |
>=13 years | 26 (21.5) | 13 (19.1) | |
Sex | |||
Female | 49 (40.5) | 38 (55.9) | 0.05 |
Race | |||
Caucasian | 56 (45.9) | 39 (57.4) | 0.21 |
African American | 48 (39.3) | 20 (29.4) | |
Asian/Indian | 3 (2.5) | 4 (5.9) | |
Other/Unknown | 15 (12.3) | 5 (7.4) | |
ED Illness Severity | |||
ED Triage = ESI 1 or 2 | 101 (83.4) | 58 (86.6) | 0.57 |
At least 1 ED organ dysfunction | 103 (85.1) | 56 (83.6) | 0.78 |
Median initial lactate (mmol/L) | 2.2 (1.5, 3.1) | 1.4 (0.9, 2.2) | 0.001 |
Presence of Indwelling Central Line | 14 (11.6) | 17 (25.4) | 0.02 |
Complex chronic conditions (CCC) | |||
No CCC | 58 (47.9) | 28 (41.2) | 0.447 |
At least 1 CCC | 63 (52.1) | 40 (58.8) | 0.447 |
>=2 CCC | 20 (16.5) | 11 (16.2) | 1 |
Table 2.
Sepsis Protocol | Odds Ratio (95% CI) | p | ||
---|---|---|---|---|
| ||||
Yes (n=121) | No (n=68) | |||
|
||||
Length of Stay (Median hours, IQR) | ||||
PICU LOS | 69.0 (35.8–120.9) | 196.5 (100.5–339.7) | <0.001 | |
Hospital LOS | 140.0 (93.5–237.6) | 347.7 (211.8–557.9) | <0.001 | |
Illness severity score on PICU arrival (Median, IQR) | ||||
PIM2 | 1.1 (1.0, 2.1)) | 3.6 (1.0, 4.9) | 0.14 | |
PRISM | 3 (0,10) | 6 (3, 10) | 0.10 | |
PICU Care Requirements | ||||
Ever needed vasoactive support n(%) | 48 (39.6) | 18 (26.9) | 1.4 (0.9, 2.3) | 0.10 |
Ever needed invasive mechanical ventilation | 8 (6.6) | 11 (16.4) | 0.4 (0.2, 0.9) | 0.03 |
Ever needed PRBC transfusion | 8 (6.6) | 2 (3.0) | 2.2 (0.5, 10.1) | 0.3 |
Bacterial organism isolated | 42 (34.7) | 24 (35.8) | 0.9 (0.6, 1.4) | 0.7 |
Transfer to higher level of care n (%) | ||||
Floor to PICU transfer <24h | 10 (8.2) | 18 (26.9) | 0.3 (0.2, 0.6) | 0.006 |
Organ Dysfunction | ||||
Organ dysfunction free on hospital admission | 18 (14.9) | 11 (16.4) | 0.9 (0.4, 2.0) | 0.80 |
Organ dysfunction free D1 | 49 (40.5) | 9 (13.4) | 4.4 (2.0, 9.7) | <0.001 |
Organ dysfunction free D2 | 61 (50.4) | 11 (16.4) | 5.2 (2.5, 10.8) | <0.001 |
Developed new organ dysfunction on D1 or D2 | 5 (4.1) | 11 (16.4) | 0.3 (0.1, 0.7) | 0.004 |
Mortality | ||||
In hospital mortality | 4 (3.3) | 2 (2.9) | 1.1 (0.2, 5.9) | 0.9 |
Table 2 provides comparison of outcomes in protocol compared to usual care patients. Protocol patients were more likely to be OD free on hospital day 1 (RR 4.4, 95% CI 2.0, 9.7) and hospital day 2 (RR 5.2, 95% CI 2.5, 10.8). Protocol patients without ED OD were less likely to develop new OD in the first 2 hospital days (RR 0.3, 95% CI 0.1, 0.7). Protocol patients compared to usual care patients had shorter PICU and hospital LOS, and were less likely to have subsequent transfer to a higher level of care if initially admitted to the inpatient floor within 24 hours of ED arrival (RR 0.3, 95% CI 0.2, 0.6). There was no difference in hospital mortality between groups.
Detailed process metrics related to protocol compared to usual care are shown in Table 3. Protocol patients had shorter time to initial IV antibiotics, initial IV fluid bolus, and third IV fluid bolus compared to usual care patients. Protocol patients also received a higher total volume of fluid per kg in the ED compared to usual care patients.
Table 3.
Sepsis Protocol | Odds Ratio (95% CI) | p | ||
---|---|---|---|---|
| ||||
Median minutes (IQR) | Yes (n=121) | No (n=68) | ||
|
||||
Time from ED triage to initial Abx | 102.5 (55–165) | 175 (104–281) | <0.001 | |
Time from ED triage to initial NS bolus | 64 (28–106) | 88 (39–196) | 0.01 | |
Time from ED triage to third NS bolus | 192 (109–254) | 407 (226–802) | <0.001 | |
Total ED fluid received (median, IQR in ml/kg) | 55 (37, 60) | 39 (20, 53) | 0.004 | |
% with initial IVF <60 min n(%) | 52 (46.0) | 23 (36.5) | 1.4 (0.8, 2.7) | 0.25 |
% with IVF <120 min | 92 (81.4) | 41 (65.1) | 2.2 (1.1, 4.6) | 0.02 |
% getting initial abx within 60 minutes | 30 (26.3) | 8 (12.3) | 2.5 (1.1, 5.8) | 0.03 |
% getting initial abx within 120 minutes | 64 (56.1) | 18 (28.1) | 3.2 (1.7, 6.3) | 0.001 |
ED LOS | 228 (150, 342) | 243 (168, 366) | 0.63 |
We performed univariate analysis to determine candidate confounding variables, and included the following variables in a multivariable model: presence of any comorbid condition, presence of a central line, PIM-2 score, receipt of antibiotics in less than 120 minutes from ED triage, and receipt of initial IV fluids in less than 120 minutes from ED triage. The following variables were considered in univariate analysis but were not included in the final model: age, race, number of comorbid conditions, and ED triage level. In our multivariable logistic regression model, utilization of the ED protocol remained independently associated with complete resolution of OD by hospital day 2 (adjusted OR 4.2, 95% CI 1.7, 10.4). (Table 4)
Table 4.
Organ Failure Free Day 2 | OR (adjusted) | p | 95% CI |
---|---|---|---|
ED sepsis protocol | 4.23 | 0.002 | 1.7, 10.4 |
Sex | 1.23 | 0.59 | 0.6,2.6 |
Central line | 0.95 | 0.98 | 0.3, 2.8 |
PIM-2 score | 0.61 | <0.005 | 0.5, 0.8 |
Any comorbidity | 0.92 | 0.79 | 0.4, 1.9 |
Antibiotics < 120 min | 0.93 | 0.9 | 0.4, 2.2 |
Bolus < 120 min | 3.1 | 0.04 | 1.1, 8.8 |
Discussion
We demonstrated in this single center retrospective study that children with severe sepsis treated using a protocolized care guideline and order set in the ED compared to those treated with non-protocolized usual care were more likely to be free of organ dysfunction on hospital day 2. The benefit of treatment using a protocolized guideline could not be explained by baseline differences in severity of illness or pre-existing comorbid conditions. Our findings extend the work of others that protocolized care improves timeliness and is associated with decreased morbidity in pediatric severe sepsis. 4–6, 31 Specifically, we demonstrate that use of a protocolized ED guideline is independently associated with reduced morbidity related to organ dysfunction in pediatric severe sepsis
In 2012, we implemented a protocolized plan to organize and streamline resuscitative and antimicrobial therapy for pediatric patients with suspected severe sepsis in our ED. Between 2012 and 2014, although there was not full penetrance of use of the protocolized approach, our data show that there was not a differential in application of the approach based on measured severity of illness.
This study provides evidence that implementation of protocolized acute care therapies decreased the presence of organ dysfunction at hospital day 2. We chose day 2 because evidence suggests that over 90% of sepsis associated organ dysfunction occurs by the second hospital day16,17, and because we were interested in identifying a proximal outcome measure that was likely to be influenced by initial ED resuscitation. Such proximal outcome measures are important components of evaluating the success of novel ED based diagnostics and therapeutics, particularly because mortality in this setting is quite low, and single center studies are unlikely to be powered to detect differences in mortality. This data is supported by a recent single center study by Arikan et al. demonstrating decreased acute kidney injury in children treated with an ED based sepsis protocol.31
We did not identify any statistical difference in the mortality rate by protocolized care compared to usual care. However, attention to mortality differences should be included in future assessments of protocolized care in pediatric sepsis as our study was limited by the small number of patients who died.
The precise reasons behind the success of our protocolized care strategy are likely multi factorial. We note with interest that neither the inclusion of timeliness of antibiotics nor initial IV fluid bolus in our multivariable regression models could fully account for the improved outcomes observed in patients treated with the sepsis protocol, indicating that factors other than timely therapy are likely to be important. One possibility is that improvements in care come not only from improved timeliness, but also from group level processing by the care team that comes from the overt statement that a patient is being cared for within the sepsis protocol.
It is also important to interpret this study in the context of several recent large randomized clinical trials in adults which compared patient outcomes following early goal-directed therapy versus standardized or usual care in the US, Britain, and Australia/New Zealand.29–31 These studies did not demonstrate outcome differences based on method used. However, the objective of these trials was to compare protocol-based early goal-direct therapy to an alternative protocol-based therapy. Even the inclusion of a “usual care” arm in one of these studies did not exclude use of a local protocolized approach. These studies indicate that all components of early goal directed therapy (EGDT) including routine measurement of central venous pressure (CVP) and central venous oxygen saturation (ScvO2) may not be necessary in all adults with septic shock. Notably, neither our protocolized approach nor non-protocolized usual care approach to resuscitation of pediatric septic shock in our ED included routine CVP and ScvO2 monitoring. Unlike these trials, our objective was to compare protocolized care (which is early and goal-directed but not as prescriptive as formal EGDT) to a non-protocolized approach.
There are several limitations to this study. It is important to note the possibility that there are unmeasured confounders that explain worse outcomes in patients who did not receive the protocol that are independent of the protocol itself. This would likely be some unmeasured “complexity” factor that makes sepsis recognition challenging and also is associated with poor outcomes. We did not note significant differences between the groups in terms of ICU based severity scores (PRISM-III and PIM-2), although it is important to note that these scores are determined after ED therapies are received. There are currently no widely utilized pediatric ED based severity scores, though it would be interesting in the future to apply one such candidate scoring system, the pediatric risk of admission (PRISA) score35 in this population. Conversely, it is possible that there was misclassification bias in that some patients did in fact receive care that was the same as protocolized care but did not use the associated order set, and thus would be included in the usual care group. However, this would have biased the study towards the null hypothesis. In addition, because this was a single center study, the external validity of our findings to other centers is not clear. As an important corollary to this, results of sepsis studies involving fluid resuscitation in the United States should be interpreted with great caution in resource-limited settings where aggressive fluid therapy has been shown to be associated with increased mortality.36 However, while the contents and directives of a protocol may need to be region- and site-specific, a protocolized approach to a complex resuscitative strategy may still find overall utility in various settings.
In conclusion, we found that pediatric patients with severe sepsis treated according to a protocolized care guideline and order set in the ED had lower rates of organ dysfunction at two days following ED presentation than patients treated per usual care. Patients cared for within the sepsis guideline also had, improved processes of care and decreased hospital length of stay. This study suggests that protocololized based approach to emergency department therapy for children with sepsis may improve both process of care and patient outcomes.
Supplementary Material
Acknowledgments
None of the authors of this manuscript have any conflicts of interest to report. FB received career development support from NIH NHLBI K12-HL109009 and 1K23HD082368. SW received support from NIH NICHD K12-HD047349 and NIH NIGMS K23-GM110496. Funders were not involved in design and conduct of the study; collection, management, analysis, interpretation of the data; preparation, review, or approval of the manuscript. Fran Balamuth had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis, and conducted the data analysis.
Footnotes
Reprints will not be ordered.
Financial Disclosure: The authors have no financial relationships relevant to this article to disclose.
Conflict of Interest: The authors have no conflicts of interest to disclose.
References
- 1.Odetola FO, Gebremariam A, Freed GL. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics. 2007 Mar;119(3):487–494. doi: 10.1542/peds.2006-2353. [DOI] [PubMed] [Google Scholar]
- 2.Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med. 2005 May;6(3 Suppl):S3–5. doi: 10.1097/01.PCC.0000161289.22464.C3. [DOI] [PubMed] [Google Scholar]
- 3.Balamuth F, Carr B, Kallan MJ, Alpern E. Pediatric Academic Societies. Vancouver, British Columbia, Canada: 2014. Epidemiology and Outcomes of Pediatric Sepsis in the United States. [Google Scholar]
- 4.Cruz AT, Perry AM, Williams EA, Graf JM, Wuestner ER, Patel B. Implementation of goal-directed therapy for children with suspected sepsis in the emergency department. Pediatrics. 2011 Mar;127(3):e758–766. doi: 10.1542/peds.2010-2895. [DOI] [PubMed] [Google Scholar]
- 5.Larsen GY, Mecham N, Greenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics. 2011 Jun;127(6):e1585–1592. doi: 10.1542/peds.2010-3513. [DOI] [PubMed] [Google Scholar]
- 6.Paul R, Neuman MI, Monuteaux MC, Melendez E. Adherence to PALS Sepsis Guidelines and Hospital Length of Stay. Pediatrics. 2012 Jul 2; doi: 10.1542/peds.2012-0094. [DOI] [PubMed] [Google Scholar]
- 7.Weiss SL, Fitzgerald JC, Balamuth F, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014 Nov;42(11):2409–2417. doi: 10.1097/CCM.0000000000000509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015 May 15;191(10):1147–1157. doi: 10.1164/rccm.201412-2323OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Paul R, Melendez E, Stack A, Capraro A, Monuteaux M, Neuman MI. Improving Adherence to PALS Septic Shock Guidelines. Pediatrics. 2014 Apr 7; doi: 10.1542/peds.2013-3871. [DOI] [PubMed] [Google Scholar]
- 10.Scott H. Platform presentation at Pediatric Academic Societies; Baltimore, MD. May 2016. [Google Scholar]
- 11.Leclerc F, Leteurtre S, Duhamel A, et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med. 2005 Feb 15;171(4):348–353. doi: 10.1164/rccm.200405-630OC. [DOI] [PubMed] [Google Scholar]
- 12.Czaja AS, Zimmerman JJ, Nathens AB. Readmission and late mortality after pediatric severe sepsis. Pediatrics. 2009 Mar;123(3):849–857. doi: 10.1542/peds.2008-0856. [DOI] [PubMed] [Google Scholar]
- 13.Typpo KV, Petersen NJ, Hallman DM, Markovitz BP, Mariscalco MM. Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit. Pediatr Crit Care Med. 2009 Sep;10(5):562–570. doi: 10.1097/PCC.0b013e3181a64be1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dalton HJ, Carcillo JA, Woodward DB, Short MA, Williams MD. Biomarker response to drotrecogin alfa (activated) in children with severe sepsis: results from the RESOLVE clinical trial*. Pediatr Crit Care Med. 2012 Nov;13(6):639–645. doi: 10.1097/PCC.0b013e318250ad48. [DOI] [PubMed] [Google Scholar]
- 15.Curley MA, Wypij D, Matthay MA. Sedation protocol for critically ill pediatric patients--reply. JAMA. 2015 May 5;313(17):1754–1755. doi: 10.1001/jama.2015.3462. [DOI] [PubMed] [Google Scholar]
- 16.Proulx F, Gauthier M, Nadeau D, Lacroix J, Farrell CA. Timing and predictors of death in pediatric patients with multiple organ system failure. Crit Care Med. 1994 Jun;22(6):1025–31. doi: 10.1097/00003246-199406000-00023. [DOI] [PubMed] [Google Scholar]
- 17.Weiss S. personal communication. Feb 19, 2016.
- 18.Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005 Jan;6(1):2–8. doi: 10.1097/01.PCC.0000149131.72248.E6. [DOI] [PubMed] [Google Scholar]
- 19.Balamuth F, Woodford A, Weiss S, et al. There's an App for That: An electronic health record sepsis registry and clinical protocol to improve quality of care. Pediatric Academic Societies and Society for Academic Emergency Medicine; Washington DC: 2013. [Google Scholar]
- 20.Fiks AG, Grundmeier RW, Mayne S, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013 Jun;131(6):1114–1124. doi: 10.1542/peds.2012-3122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Massino A, Italia M, Davidson LS, White P. Research Hospital Data ETL with DataExpress: A Scala DSL for Rapid ETL Configuration and Execution. Paper presented at: 3rd Annual Scala Days; 2012; London, England. [Google Scholar]
- 22.Bell LM, Grundmeier R, Localio R, et al. Electronic health record-based decision support to improve asthma care: a cluster-randomized trial. Pediatrics. 2010 Apr;125(4):e770–777. doi: 10.1542/peds.2009-1385. [DOI] [PubMed] [Google Scholar]
- 23.Gaies MG, Jeffries HE, Niebler RA, et al. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med. 2014 Jul;15(6):529–537. doi: 10.1097/PCC.0000000000000153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Slater A, Shann F, Pearson G. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med. 2003 Feb;29(2):278–285. doi: 10.1007/s00134-002-1601-2. [DOI] [PubMed] [Google Scholar]
- 25.Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996 May;24(5):743–752. doi: 10.1097/00003246-199605000-00004. [DOI] [PubMed] [Google Scholar]
- 26.Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001 Jun;107(6):E99. doi: 10.1542/peds.107.6.e99. [DOI] [PubMed] [Google Scholar]
- 27.Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199. doi: 10.1186/1471-2431-14-199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kumar A, Haery C, Paladugu B, et al. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis. 2006 Jan 15;193(2):251–258. doi: 10.1086/498909. [DOI] [PubMed] [Google Scholar]
- 29.Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010 Apr;38(4):1045–1053. doi: 10.1097/CCM.0b013e3181cc4824. [DOI] [PubMed] [Google Scholar]
- 30.Puskarich MA, Trzeciak S, Shapiro NI, et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012 Mar;19(3):252–258. doi: 10.1111/j.1553-2712.2012.01292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Akcan Arikan A, Williams EA, Graf JM, Kennedy CE, Patel B, Cruz AT. Resuscitation Bundle in Pediatric Shock Decreases Acute Kidney Injury and Improves Outcomes. J Pediatr. 2015;167:1301–5. doi: 10.1016/j.jpeds.2015.08.044. [DOI] [PubMed] [Google Scholar]
- 32.ProCESS Investigators. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014 May 1;370(18):1683–93. doi: 10.1056/NEJMoa1401602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM ProMISe Trial Investigators. Trial of early goal-directed resuscitation for septic shock. N Engl J Med. 2015 Apr 2;372(14):1301–11. doi: 10.1056/NEJMoa1500896. for septic shock. [DOI] [PubMed] [Google Scholar]
- 34.ARISE Investigators; ANZICS Clinical Trials Group. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014 Oct 16;371(16):1496–506. doi: 10.1056/NEJMoa1404380. [DOI] [PubMed] [Google Scholar]
- 35.Chamberlain JM, Patel KM, Ruttimann UE, Pollack MM. Pediatric risk of admission (PRISA): a measure of severity of illness for assessing the risk of hospitalization from the emergency department. Ann Emerg Med. 1998 Aug;32(2):161–169. doi: 10.1016/s0196-0644(98)70132-5. [DOI] [PubMed] [Google Scholar]
- 36.Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483–95. doi: 10.1056/NEJMoa1101549. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.